Persistence of COVID-19 Symptoms after Recovery in Mexican Population
Autor: | Carolina Rodríguez-Quiñones, Hamurabi Gamboa-Rosales, Fuensanta Reyes-Escobedo, Julio Ramírez-Barranco, Susana Godina-González, Jorge I. Galván-Tejada, Bruno Rivas-Santiago, Karen E. Villagrana-Bañuelos, José M. Celaya-Padilla, Karla Herrera-García, Irma González-Curiel, Laura A. Zanella-Calzada, Juan Daniel De Luna Amaro, Cintya Fabiola Herrera-García, Alberto R. Cervantes-Villagrana, Monica I. Martinez-Acuna, Jocelyn L. Ruiz de Avila, Carlos E. Galván-Tejada |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Pediatrics Nausea Health Toxicology and Mutagenesis Anosmia persistent symptoms lcsh:Medicine Disease Article 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Pandemic Medicine Humans 030212 general & internal medicine Mexico recovered from COVID business.industry SARS-CoV-2 Public health lcsh:R Public Health Environmental and Occupational Health COVID-19 post-COVID syndrome Middle Aged Confidence interval Infectious disease (medical specialty) Relative risk Case-Control Studies Chronic Disease Female medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | International Journal of Environmental Research and Public Health Volume 17 Issue 24 International Journal of Environmental Research and Public Health, Vol 17, Iss 9367, p 9367 (2020) |
ISSN: | 1660-4601 1661-7827 |
Popis: | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19. |
Databáze: | OpenAIRE |
Externí odkaz: |